e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Advances in asthma pharmacology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice
Y. Karaman-Kutluay (Ankara, Turkey), Y. Kaya-Yasar (Trabzon, Turkey), T. Bozkurt (Ankara, Turkey), S. Celik Onder (Ankara, Turkey), I. Sahin-Erdemli (Ankara, Turkey)
Source:
International Congress 2019 – Advances in asthma pharmacology
Session:
Advances in asthma pharmacology
Session type:
Poster Discussion
Number:
3879
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Karaman-Kutluay (Ankara, Turkey), Y. Kaya-Yasar (Trabzon, Turkey), T. Bozkurt (Ankara, Turkey), S. Celik Onder (Ankara, Turkey), I. Sahin-Erdemli (Ankara, Turkey). Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice. 3879
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Hydrogen sulphide donors prevent hyperreactivity of mice tracheas in an in vitro lipopolysaccharide-induced inflammation model
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018
In vivo blockade of CTLA-4 counteracts inhalation tolerance and leads to development of allergic airway inflammation in mice repeatedly exposed to aerosolized ovalbumin
Source: Eur Respir J 2004; 24: Suppl. 48, 6s
Year: 2004
Inhalation of hydrogen gas attenuate airway inflammation and oxidative stress in allergic asthmatic mice
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017
A zinc chelator TPEN attenuates airway hyperresponsiveness and airway inflammation in mice
in vivo
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Overexpression of peroxiredoxin 6 protect mice from ovalbumin-induced airway inflammation and hypersecretion of MUC5AC by reducing ROS levels
Source: Annual Congress 2011 - Animal models of airway inflammation
Year: 2011
Inhaled cationic salts modulate macrophage function to reduce inflammation during LPS induced lung injury
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Airway hyperresponsiveness to histamine induced by repetitive intraperitoneal injection of lipopolysacharide and the involvement of nitric oxide generation in guinea pigs
Source: Eur Respir J 2005; 26: Suppl. 49, 367s
Year: 2005
Intratracheal instillation of antigen-pulsed macrophages mediates repression of allergic airway inflammation
Source: Eur Respir J 2003; 22: Suppl. 45, 483s
Year: 2003
Endogenous hydrogen sulfide reduces airway hyperresponsiveness and airway inflammation in a rat model of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
Ovalbumin challenge causes epithelial damage in murine airways by a substance P mediated generation of reactive oxygen species
Source: Eur Respir J 2002; 20: Suppl. 38, 94s
Year: 2002
iNOS depletion completely diminishes reactive nitrogen-species formation after an allergic response
Source: Eur Respir J 2002; 20: 609-616
Year: 2002
Regulated lung-specific overexpression of nitric oxide induces airway hyperresponsiveness in mice
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002
LSC 2011 Abstract: Combined nasal exposure to sodium hypochlorite and ovalbumin induces airway hyperreactivity in mice through activation of the TRPA1 channel and mast cells
Source: Annual Congress 2011 - Environmental exposure and disease mechanisms
Year: 2011
Endotoxin interferes with allergy-induced airway inflammation in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 348s
Year: 2004
Dexamethasone reduces lung inflammation induced by alveolar stretch in mice
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
Endotoxin potentiates allergic airway inflammation in ovalbumin sensitised and challenged mice
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Chronic nitric oxide inhibition modulates inflammatory cells apoptosis induced by dexamethasone in guinea pigs with chronic airway inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 368s
Year: 2005
Inhalation of nano-scaled titianium dioxide particles aggravates airway inflammation in allergen-challenged mice
Source: Annual Congress 2011 - Environmental exposure and disease mechanisms
Year: 2011
Azithromycin prevents airway epithelial barrier dysfunction induced by sulphur dioxide inhalation
Source: Virtual Congress 2020 – Cutting edge science: novel molecules and mechanisms of airway diseases
Year: 2020
Modulation of chronic airway inflammation in guinea pigs by oral tolerance: effects in lung mechanics, cellular infiltration and nitric oxide production
Source: Eur Respir J 2002; 20: Suppl. 38, 382s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept